Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Frystyk

Showing results (91-100 of 292) with videos related to

Pageof 30
Sort By:
Frontiers in Endocrinology|June 19, 2023
Heritability and circulating concentrations of pregnancy-associated plasma protein-A and stanniocalcin-2 in elderly monozygotic and dizygotic twinsRikke Hjortebjerg, Dorthe Almind Pedersen, Jonas Mengel-From, et al.
BMJ Open|March 19, 2024
Home-based Intervention with Semaglutide Treatment of Neuroleptic-Related Prediabetes (HISTORI): protocol describing a prospective, randomised, placebo controlled and double-blinded multicentre trialAshok Ainkaran Ganeshalingam, Nicolai Gundtoft Uhrenholt, Sidse Arnfred, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 20, 2012
The production and regulation of IGF and IGFBPs in human adipose tissue culturesMette Faurholdt Gude, Jan Frystyk, Allan Flyvbjerg, et al.
European Journal of Endocrinology|July 27, 2006
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controlsDorte Glintborg, Marianne Andersen, Claus Hagen, et al.
BMC Nephrology|April 6, 2013
Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover studyMark Reinhard, Jan Frystyk, Bente Jespersen, et al.
Clinical Biochemistry|December 10, 2014
PAPP-A and IGFBP-4 fragment levels in patients with ST-elevation myocardial infarction treated with heparin and PCIRikke Hjortebjerg, Søren Lindberg, Søren Hoffmann, et al.
The Journal of Clinical Endocrinology and Metabolism|October 29, 2004
Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjectsJian-Wen Chen, Kurt Højlund, Henning Beck-Nielsen, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 3, 2008
Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney diseaseYing Kuan, Joanne Surman, Jan Frystyk, et al.
Scandinavian Journal of Gastroenterology|April 25, 2007
The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's diseaseMartin Eivindson, Henning Grønbaek, Kristin Skogstrand, et al.
BMC Endocrine Disorders|April 15, 2014
Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetesZhulin Ma, Jens Sandahl Christiansen, Torben Laursen, et al.
Pageof 30

Showing results (91-100 of 292) with videos related to

Sort By:
Pageof 30
Frontiers in Endocrinology|June 19, 2023
Heritability and circulating concentrations of pregnancy-associated plasma protein-A and stanniocalcin-2 in elderly monozygotic and dizygotic twinsRikke Hjortebjerg, Dorthe Almind Pedersen, Jonas Mengel-From, et al.
BMJ Open|March 19, 2024
Home-based Intervention with Semaglutide Treatment of Neuroleptic-Related Prediabetes (HISTORI): protocol describing a prospective, randomised, placebo controlled and double-blinded multicentre trialAshok Ainkaran Ganeshalingam, Nicolai Gundtoft Uhrenholt, Sidse Arnfred, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 20, 2012
The production and regulation of IGF and IGFBPs in human adipose tissue culturesMette Faurholdt Gude, Jan Frystyk, Allan Flyvbjerg, et al.
European Journal of Endocrinology|July 27, 2006
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controlsDorte Glintborg, Marianne Andersen, Claus Hagen, et al.
BMC Nephrology|April 6, 2013
Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover studyMark Reinhard, Jan Frystyk, Bente Jespersen, et al.
Clinical Biochemistry|December 10, 2014
PAPP-A and IGFBP-4 fragment levels in patients with ST-elevation myocardial infarction treated with heparin and PCIRikke Hjortebjerg, Søren Lindberg, Søren Hoffmann, et al.
The Journal of Clinical Endocrinology and Metabolism|October 29, 2004
Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjectsJian-Wen Chen, Kurt Højlund, Henning Beck-Nielsen, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 3, 2008
Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney diseaseYing Kuan, Joanne Surman, Jan Frystyk, et al.
Scandinavian Journal of Gastroenterology|April 25, 2007
The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's diseaseMartin Eivindson, Henning Grønbaek, Kristin Skogstrand, et al.
BMC Endocrine Disorders|April 15, 2014
Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetesZhulin Ma, Jens Sandahl Christiansen, Torben Laursen, et al.
Pageof 30